We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

204 hedge funds and large institutions have $1.1B invested in Sage Therapeutics in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $5.76M | Put options by funds: $3.67M

17% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 24

15% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 61

2.38% more ownership

Funds ownership: 94.92% → 97.3% (+2.4%)

2% more funds holding

Funds holding: 200 → 204 (+4)

11% less capital invested

Capital invested by funds: $1.23B → $1.1B (-$138M)

Holders
204
Holders Change
+4
Holders Change %
+2%
% of All Funds
2.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
70
Reduced
61
Closed
24
Calls
$5.76M
Puts
$3.67M
Net Calls
+$2.09M
Net Calls Change
-$5.32M

Top Buyers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
+$22M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$14.8M
3
State Street
State Street
Massachusetts
+$13.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$9.96M
5
BBA
Baker Bros. Advisors
New York
+$9.39M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$30.2M
2
CAC
Cowen and Company
New York
-$20.9M
3
JP Morgan Chase
JP Morgan Chase
New York
-$11.9M
4
Morgan Stanley
Morgan Stanley
New York
-$11.2M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
PWMG
176
Private Wealth Management Group
New Jersey
$2.9K – – –
NECFA
177
New England Capital Financial Advisors
Connecticut
$2.51K – – –
CIBC Private Wealth Group
178
CIBC Private Wealth Group
Georgia
$2.51K +$3.23K +140 New
AF
179
Allworth Financial
California
$2.42K +$2.1K +91 +239%
GI
180
GAMMA Investing
California
$2.17K +$1.2K +52 +81%
SSB
181
Sandy Spring Bank
Maryland
$1.87K – – –
HNB
182
Huntington National Bank
Ohio
$1.82K – – –
N
183
Natixis
France
$1.78K -$713K -30,905 -100%
MPWT
184
MassMutual Private Wealth & Trust
Connecticut
$1.65K +$138 +6 +7%
AA
185
Ancora Advisors
Ohio
$1.41K – – –
SPIA
186
Steward Partners Investment Advisory
New York
$937 – – –
TC
187
Truvestments Capital
Florida
$731 – – –
FWM
188
FSA Wealth Management
Massachusetts
$656 – – –
LWCFA
189
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$645 – – –
CA
190
Continuum Advisory
Idaho
$617 +$1.15K +50 New
VCM
191
Versant Capital Management
Arizona
$562 – – –
BTI
192
Blue Trust Inc
Georgia
$560 +$531 +23 +329%
GRP
193
Global Retirement Partners
California
$356 – – –
BIA
194
Bell Investment Advisors
California
$338 – – –
FFA
195
Farther Finance Advisors
California
$197 – – –
AWM
196
Avior Wealth Management
Nebraska
$187 +$231 +10 New
SC
197
SouthState Corp
Florida
$169 – – –
JWA
198
JFS Wealth Advisors
Pennsylvania
$150 – – –
SIC
199
SJS Investment Consulting
Ohio
$150 – – –
WWM
200
Wolff Wiese Magana
California
$132 – – –
6 7
8
9 10

SAGE Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q1 2024, worth a combined $1.1B — down 11% from $1.23B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SAGE positions and 24 closed out — a net gain of 4 holders — while 70 added to existing stakes and 61 trimmed.

The largest buyer was Bellevue Group, adding an estimated $22M. The largest seller was Wellington Management Group, cutting an estimated $30.2M.

  • 204 institutional investors held Sage Therapeutics (SAGE) as of Q1 2024, up from 200 in Q4 2023.
  • Funds reported $1.1B of Sage Therapeutics stock for Q1 2024, down 11% quarter-over-quarter.
  • 28 funds opened new Sage Therapeutics positions in Q1 2024 and 24 closed out, a net change of +4 holders.
  • The largest Sage Therapeutics buyer in Q1 2024 was Bellevue Group, an estimated $22M added.
  • The largest Sage Therapeutics seller in Q1 2024 was Wellington Management Group, an estimated $30.2M sold.

Based on aggregated 13F filings for Q1 2024.